Lightcalls.com
 

As the recently made known year be...

As the recently made known year begins, supplements for weight los are being advertised everywhere (and this magazine is no exception). united of these supplements is CLA, or conjugated linoleic acid. lately published studies have shed any light on how this fat-loss aid may work.

"We have identified a specific isomer (trans-10, cis-12) of CLA that causes mature human fat solitary abode; squalids to lose their fat and become smaller," explains Michael McIntosh, PhD RD of the University of North Carolina-Greensboro, who headed the investigation (published in the September 9 2005 issue of the Journal of Biological Sciences). Unfortunately, the research also found that this isomer obstructs human fat cells from taking up grape-sugar and fatty acids, which could increase kindred sugar and lipids and as a be the effect increase the risk of diabetes and cardiovascular disease. More research is privationed on the trans-10, cis-12 CLA isomer of CLA in humans and potential side effects

if it be not that other CIA studies using a mixture of CLA isomers have shown that CLA causes safe fat los principally of the research involves brace isomers--as do most store-bought CLA complements "CLA supplements sold commercially are reported to contain equal amounts of trans-10, cis-12 CLA and cis-9, trans-11 CLA," McIntosh says.



In the mostly recent of the weight-loss studies, researchers build that when 134 healthy overweight adults took CLA for 24 month not single was the supplement well tolerated, if it be not that it aided in fat los and possibly helped the individuals maintain a lower weight. This studious mood was reported in the April 2005 Journal of Nutrition.

For now, consider the following when taking CLA: Talk to your health care practitioner before beginning any weight-loss or supplementation regimen, and adopt a balanced diet cheap in sugar and fats. the one and the other will ensure a healthier fresh year.

COPYRIGHT 2006 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2006 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.